Descrição

The study protocol design for evaluating Lactobacillus plantarum 299v supplementation in cancer patients receiving home enteral nutrition is outlined, including randomization and blinding procedures.

Figure 1

Flowchart

Source Paper

The use of Lactobacillus plantarum 299v (DSM 9843) in cancer patients receiving home enteral nutrition - study protocol for a …

Nutrition journal (2020)

PMID: 32917221

DOI: 10.1186/s12937-020-00598-w

Cite This Figure

![Figure 1: The study protocol design for evaluating Lactobacillus plantarum 299v supplementation in cancer patients receiving home enteral nutrition is outlined, including randomization and blinding procedures.]()

> Source: Karolina Kaźmierczak-Siedlecka et al. "The use of Lactobacillus plantarum 299v (DSM 9843) in cancer patients receiving ." *Nutrition journal*, 2020. PMID: [32917221](https://pubmed.ncbi.nlm.nih.gov/32917221/)

<figure>
  <img src="" alt="The study protocol design for evaluating Lactobacillus plantarum 299v supplementation in cancer patients receiving home enteral nutrition is outlined, including randomization and blinding procedures." />
  <figcaption>Figure 1. The study protocol design for evaluating Lactobacillus plantarum 299v supplementation in cancer patients receiving home enteral nutrition is outlined, including randomization and blinding procedures.<br>  Source: Karolina Kaźmierczak-Siedlecka et al. "The use of Lactobacillus plantarum 299v (DSM 9843) in cancer patients receiving ." <em>Nutrition journal</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32917221/">32917221</a></figcaption>
</figure>

Evidências Relacionadas

Lactobacillus plantarum para Irritable Bowel Syndrome (IBS)

Nota B · 5 estudos